Gland Pharma consolidated net profit rises 12.32% in the September 2025 quarter

Sales rise 5.77% to Rs 1486.88 crore

Net profit of Gland Pharma rose 12.32% to Rs 183.68 crore in the quarter ended September 2025 as against Rs 163.53 crore during the previous quarter ended September 2024. Sales rose 5.77% to Rs 1486.88 crore in the quarter ended September 2025 as against Rs 1405.83 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	1486.88	1405.83	6
OPM %	21.11	21.13	-
PBDT	390.23	350.60	11
PBT	283.92	256.78	11
NP	183.68	163.53	12

Powered by Capital Market - Live News